Implantable medical device for generating cardiac pressure-volume loop and optimizing therapy

• US 7,580,746 B2
• Filed: 12/07/2005
• Issued: 08/25/2009
• Est. Priority Date: 12/07/2005
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Wang, Sophia, Zhang, Yongxing, Gilkerson, James O., Zhang, Yunlong
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): LEE, YUN H
• Application Number:
  US11/296,732
• Publication Number:
  US 20070129765A1
• Time in Patent Office: 1,357 Days
• Field of Search: 607/17, 607/18, 607/23, 607/24
• US Class Current: 607/17
• CPC Class Codes: A61B 7/00 Instruments for auscultation
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/36564 controlled by blood pressure
• CPC Class Codes: A61N 1/36578 controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

An implantable medical device for generating a cardiac pressure-volume loop, the implantable medical device comprising a pulse generator including control circuitry, a first cardiac lead including a proximal end and a distal end and coupled to the pulse generator at the proximal end, a first electrode located at the distal end of the cardiac lead and operatively coupled to the control circuitry, a sound sensor operatively coupled to the control circuitry, and a pressure sensor operatively coupled to the control circuitry, wherein the implantable medical device is adapted for measuring intracardiac impedance. A method of using the implantable medical device to optimize therapy delivered to the heart.

Claims

1. A method of generating a pressure-volume loop for a heart using an implantable medical device including a pulse generator having control circuitry, a first cardiac lead including a proximal end and a distal end, the cardiac lead coupled to the pulse generator at the proximal end, a first electrode located at the distal end of the cardiac lead and operatively coupled to the control circuitry, a sound sensor, and a pressure sensor, wherein the medical device is adapted to measure an intracardiac impedance using the first electrode, wherein the sounds sensor is coupled to the housing, and wherein the control circuitry is adapted to receive data from the sounds sensor, the pressure sensor and the first electrode and generate a pressure-volume loop using the sound, pressure and impedance data, the method comprising:

creating a first corner of the pressure-volume loop by recording a first cardiac pressure and a first cardiac volume at a first time associated with an S1 heart sound;

creating a second corner of the pressure-volume loop by recording a second cardiac pressure and a second cardiac volume at a second time at which cardiac volume starts decreasing;

creating a third corner of the pressure-volume loop by recording a third cardiac pressure and a third cardiac volume at a third time associated with an S2 heart sound; and

creating a fourth corner of the pressure-volume loop by recording a fourth cardiac pressure and a fourth cardiac volume at a fourth time at which the cardiac volume increases rapidly.

2. The method of claim 1, wherein the cardiac volume is calculated based on an intracardiac impedance measured by the implantable medical device.

3. The method of claim 1, wherein the pressure-volume loop is used to measure a cardiac volume.

4. The method of claim 1, further comprising generating a baseline pressure-volume loop from pressure, volume and sound data, storing the baseline pressure-volume loop in the control circuitry, generating a second pressure-volume loop from pressure, volume and sound data at a specified interval, comparing the second press-volume loop to the baseline pressure-volume loop to determine if a cardiac parameter is changing, and if the cardiac parameter changes more than a predetermined amount, modifying a therapy delivered to the heart.

5. The method of claim 4, wherein the cardiac parameter is selected from the group consisting of a cardiac pressure, cardiac volume, an ejection fraction, a derivative of cardiac pressure, and a derivative of cardiac volume.

6. The method of claim 4, wherein the cardiac parameter comprises ejection fraction and, if the ejection fraction decreases below 50%, the therapy delivered to the heart is modified.

7. The method of claim 4, wherein the delivered therapy is selected from the group consisting of a pharmaceutical, a pacing therapy and a defibrillation shock.

8. The method of claim 1, further comprising detecting a heart rate and, if the heart rate is increasing, generating a first pressure-volume loop using pressure, volume and sound data, determining whether fibrillation is occurring based on the first pressure-volume loop and, if fibrillation is occurring, delivering a defibrillation therapy.

9. The method of claim 8, wherein the method further includes generating a baseline pressure-volume loop using the implantable medical device, storing the baseline pressure-volume loop in the control circuitry, and wherein the step of determining whether fibrillation is occurring includes comparing the first pressure-volume loop to the baseline pressure-volume loop.

10. The method of claim 8, wherein, if the heart rate increases to between 120 to 165 beats per minute, the first pressure-volume loop is generated.